Iridius | $8,600,000 | (Apr 28, 2026)
SquareMind | $18,000,000 | (Apr 28, 2026)
Decade Energy | $25,763,540 | (Apr 28, 2026)
Certified by Founder
Lodge
NRG Therapeutics
start up
United Kingdom
- Stevenage, Hertfordshire
- 09/09/2025
- Series B
- $67,835,242
Mitochondrial therapeutics for the treatment of neurodegenerative diseases
- Industry Biotechnology Research
- Website https://www.nrgtherapeutics.com/#3
- LinkedIn https://www.linkedin.com/company/nrgtherapeutics/
TriFetch | $1,900,000 | (Apr 28, 2026)
Fathom Therapeutics | $47,000,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)
Zócalo Health | $15,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)